GlobeNewsWire · MLYS · October 22, 2026

Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026

Get the app for more

Explore stock news, insights and company research.